Shopping Cart

Pyobacteriophage complex 1 box include 1 vials X 100 ml NEW

Pyobacteriophage complex  1 box include 1 vials X 100 ml NEW
Product Code :Pyobacteriophage 100 ml
Availability :In Stock
  • $79.00

Free Shipping

Shipping time 12-14 days.

Ask a question



TRADE NAME

 Complex pyobacteriophage

DOSAGE FORM

Solution for oral, local and external administration

SHELF LIFE

2 years

MANUFACTURER

NPO Microgen, 177, Bratskaya str., Perm, Perm Territory, 614089 Russia

Presentation

20 ml, 100 ml vials Eight 20ml vials in each cardboard package with a package insert. One 100ml vials in each cardboard package with a package insert.

Ingredients

1 ml of the drug contains the active substance:
  • sterile filtrate of phage lysates of Staphylococcus, Enterococcus, Strep-tococcus, Pseudomonas aeruginosa, Klebsiella pneumoniae, Klebsiella oxytoca, enteropathogenic Escherichia coli, Proteus vulgaris, P.mirabilis - 1 ml.
Excipients:
  • preservative - 8-hydroxyquinoline sulfate monohydrate - 0.0001 g/ml (estimated content); or
  • 8-hydroxyquinoline sulfate monohydrate - 0.0001 g/ml (equal to 8-hydroxyquinoline sulfate, estimated content).

Indications

  • diseases of the ear, nose, throat, respiratory tract and lungs - inflammation of the sinuses, middle ear, tonsillitis, pharyngitis, laryngitis, tracheitis, bronchitis, pneumonia, pleurisy;
  • surgical infections - festering wounds, burns, abscesses, cellulitis, boils, carbuncles, hidradenitis, felon, perirectitis, mastitis, bursitis, osteomyelitis;
  • urogenital infections - urethritis, cystitis, pyelonephritis, colpitis, endometritis, salpingo-oophoritis;
  • post-traumatic conjunctivitis, keratoconjunctivitis, purulent corneal ulcers and iridocyclitis;
  • enteric infections - gastroenterocolitis, cholecystitis, dysbiosis;
  • Generalized septic diseases;
  • purulent inflammatory diseases of newborns - omphalitis, pyoderma, conjunctivitis, gastroenterocolitis, sepsis, etc.;
  • other diseases caused by staphylococci, streptococci, enterococci, Proteus, Klebsiella pneumoniae and klebsiella oxytoca, Pseudomonas aeruginosa and Escherichia coli.
  • For the prevention purposes the drug is use for the treatment of operational and newly infected wounds, for the prevention of hospital-acquired infections on epidemic indications.
  • An important condition for the effective phage therapy is a preliminary determination of the phage sensitivity of the pathogen.

Permitted to buy without prescription

Write a review

Note: HTML is not translated!
    Bad           Good